CA 19.9 / SERUM

image not found

NABL Cap Accredited 
The CA 19.9 test measures a tumor-associated antigen in serum, commonly used to support diagnosis and monitor treatment in pancreatic and gastrointestinal cancers. Although not suitable for screening, it provides useful information when interpreted alongside imaging and clinical evaluation. Metropolis Healthcare uses precise immunoassay technology to ensure accurate and consistent results. This test helps clinicians assess disease activity, response to therapy, and detect recurrence when clinically indicated.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 1,650.00

Sample Type: SERUM

Fasting Not Required


Notes: C0007

Frequently Asked Questions (FAQ's):

What does this test include?
This test measures CA 19.9 antigen levels in serum, performed with reliability by Metropolis Healthcare.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses highly sensitive immunoassays to quantify CA 19.9 accurately.

Who should take this test?
Patients with suspected or diagnosed pancreatic or gastrointestinal malignancies can benefit at Metropolis Healthcare.

Can this test diagnose cancer alone?
No, Metropolis Healthcare interprets CA 19.9 results only alongside imaging and clinical findings.

Do I need to fast before this test?
No fasting is required; Metropolis Healthcare only needs a serum sample.

What do elevated levels indicate?
High levels at Metropolis Healthcare may suggest malignancy or certain benign conditions like inflammation.

How is this test used in follow-up?
Metropolis Healthcare uses changes in CA 19.9 levels to monitor treatment response and possible recurrence.

How long does it take to get results?
Metropolis Healthcare provides timely results to support informed clinical decision-making.

 
 

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab